1 This LICENSE AGREEMENT (the “Agreement”) is made as of September 15, 2014 (the “Effective Date”) by and between Gilead
![China Product Supply Agreement Legal Forms And Business Templates In Manufacturing Supply Agreement Templates - 10+ Pro… | Business template, Legal forms, Agreement China Product Supply Agreement Legal Forms And Business Templates In Manufacturing Supply Agreement Templates - 10+ Pro… | Business template, Legal forms, Agreement](https://i.pinimg.com/originals/7d/20/d9/7d20d9843b4d64cb737c7fb67ff4f0bd.png)
China Product Supply Agreement Legal Forms And Business Templates In Manufacturing Supply Agreement Templates - 10+ Pro… | Business template, Legal forms, Agreement
SUN PHARMA on LinkedIn: We have entered into an exclusive distribution, license, and supply… | 22 comments
![License, Development and Supply Agreement, dated as of March | Aquestive Therapeutics, Inc. | Business Contracts | Justia License, Development and Supply Agreement, dated as of March | Aquestive Therapeutics, Inc. | Business Contracts | Justia](https://resources.contracts.justia.com/contract-images/de063f41547a760fac427f897eed82b8d2c9310c.jpg)
License, Development and Supply Agreement, dated as of March | Aquestive Therapeutics, Inc. | Business Contracts | Justia
![Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand](https://mma.prnewswire.com/media/1444028/Sun_Pharma_Logo.jpg?w=200)
Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand
This LICENSE AGREEMENT (the "Agreement") is made as of January 14, 2022 (the "Effective Date") by and amon
![Rigel Pharmaceuticals on Twitter: "Rigel and Knight Therapeutics enter into exclusive license and supply agreements to commercialize fostamatinib in Latin America. To learn more: https://t.co/UkQ9cmQE94 $RIGL $KHTRF https://t.co/93GOQJcbSc" / X Rigel Pharmaceuticals on Twitter: "Rigel and Knight Therapeutics enter into exclusive license and supply agreements to commercialize fostamatinib in Latin America. To learn more: https://t.co/UkQ9cmQE94 $RIGL $KHTRF https://t.co/93GOQJcbSc" / X](https://pbs.twimg.com/media/FThdq5YXoAIqvoO.jpg)